{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:16:56Z","timestamp":1790533016494,"version":"4.1.0"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2018,3,10]],"date-time":"2018-03-10T00:00:00Z","timestamp":1520640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Innovative Medicines Initiative Joint Undertaking","award":["115583"],"award-info":[{"award-number":["115583"]}]},{"DOI":"10.13039\/501100004963","name":"European Union\u2019s Seventh Framework Programme","doi-asserted-by":"publisher","award":["FP7\/2007-2013"],"award-info":[{"award-number":["FP7\/2007-2013"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wellcome Trust Investigator Award","award":["110072\/Z\/15\/Z"],"award-info":[{"award-number":["110072\/Z\/15\/Z"]}]},{"DOI":"10.13039\/501100000268","name":"BBSRC","doi-asserted-by":"crossref","award":["BB\/J004561\/1"],"award-info":[{"award-number":["BB\/J004561\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5,4]]},"DOI":"10.1093\/nar\/gky181","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T20:11:13Z","timestamp":1520021473000},"page":"4114-4128","source":"Crossref","is-referenced-by-count":46,"title":["A new class of antibacterials, the imidazopyrazinones, reveal structural transitions involved in DNA gyrase poisoning and mechanisms of resistance"],"prefix":"10.1093","volume":"46","author":[{"given":"Thomas","family":"Germe","sequence":"first","affiliation":[{"name":"Department of Biological Chemistry, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"V\u00f6r\u00f6s","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Jeannot","sequence":"additional","affiliation":[{"name":"Sanofi R&D, TSU Infectious Diseases, 1541 Avenue Marcel M\u00e9rieux, 69280 Marcy L\u2019Etoile, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Taillier","sequence":"additional","affiliation":[{"name":"Sanofi R&D, TSU Infectious Diseases, 1541 Avenue Marcel M\u00e9rieux, 69280 Marcy L\u2019Etoile, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Stavenger","sequence":"additional","affiliation":[{"name":"Antibacterial Discovery Performance Unit, Infectious Diseases Therapy Area Unit, GlaxoSmithKline, 1250 Collegeville Road, Collegeville, PA 19426, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bacqu\u00e9","sequence":"additional","affiliation":[{"name":"Sanofi R&D, TSU Infectious Diseases, 1541 Avenue Marcel M\u00e9rieux, 69280 Marcy L\u2019Etoile, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5756-6430","authenticated-orcid":false,"given":"Anthony","family":"Maxwell","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin D","family":"Bax","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, UK"},{"name":"Platform Technology and Science, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,3,10]]},"reference":[{"key":"key\n\t\t\t\t20180504013612_B1","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S1473-3099(16)30127-X","article-title":"Reflecting on the final report of the O\u2019Neill Review on Antimicrobial Resistance","volume":"16","author":"Piddock","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"key\n\t\t\t\t20180504013612_B2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1473-3099(11)70316-4","article-title":"The crisis of no new antibiotics\u2013what is the way forward","volume":"12","author":"Piddock","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"key\n\t\t\t\t20180504013612_B3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/ja.2015.98","article-title":"A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics","volume":"69","author":"Renwick","year":"2016","journal-title":"J. Antibiot. (Tokyo)"},{"key":"key\n\t\t\t\t20180504013612_B4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nbt0317-187","article-title":"Solithromycin rejection chills antibiotic sector","volume":"35","author":"Owens","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"key\n\t\t\t\t20180504013612_B5","doi-asserted-by":"crossref","first-page":"20140086","DOI":"10.1098\/rstb.2014.0086","article-title":"Time for a change: addressing R&D and commercialization challenges for antibacterials","volume":"370","author":"Payne","year":"2015","journal-title":"Philos. Trans. R Soc. Lond. B Biol. Sci."},{"key":"key\n\t\t\t\t20180504013612_B6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/472032a","article-title":"Fix the antibiotics pipeline","volume":"472","author":"Cooper","year":"2011","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180504013612_B7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrmicro3245","article-title":"ND4BB: addressing the antimicrobial resistance crisis","volume":"12","author":"Rex","year":"2014","journal-title":"Nat. Rev. Micro."},{"key":"key\n\t\t\t\t20180504013612_B8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/jac\/dkv339","article-title":"The innovative medicines initiative's new drugs for bad bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance","volume":"71","author":"Kostyanev","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"key\n\t\t\t\t20180504013612_B9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00253-011-3557-z","article-title":"Exploiting bacterial DNA gyrase as a drug target: current state and perspectives","volume":"92","author":"Collin","year":"2011","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"key\n\t\t\t\t20180504013612_B10","doi-asserted-by":"crossref","DOI":"10.1128\/ecosalplus.ESP-0010-2014","article-title":"DNA topoisomerases","volume":"6","author":"Bush","year":"2015","journal-title":"EcoSal Plus"},{"key":"key\n\t\t\t\t20180504013612_B11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/9783527659685.ch11","article-title":"Recent developments in inhibitors of bacterial type IIA topoisomeraseshan","volume-title":"Antibiotics","author":"Chan","year":"2013"},{"key":"key\n\t\t\t\t20180504013612_B12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1568026033452537","article-title":"Fluoroquinolones: action and resistance","volume":"3","author":"Drlica","year":"2003","journal-title":"Curr. Top. Med. Chem."},{"key":"key\n\t\t\t\t20180504013612_B13","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.tim.2014.04.007","article-title":"Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success","volume":"22","author":"Redgrave","year":"2014","journal-title":"Trends Microbiol."},{"key":"key\n\t\t\t\t20180504013612_B14","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1021\/bi2013905","article-title":"Drug interactions with Bacillus anthracis topoisomerase IV: biochemical basis for quinolone action and resistance","volume":"51","author":"Aldred","year":"2012","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20180504013612_B15","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1073\/pnas.1525047113","article-title":"Crystal structure and stability of gyrase-fluoroquinolone cleaved complexes from Mycobacterium tuberculosis","volume":"113","author":"Blower","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"key\n\t\t\t\t20180504013612_B16","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/nsmb.1892","article-title":"Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance","volume":"17","author":"Wohlkonig","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"key\n\t\t\t\t20180504013612_B17","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20180504013612_B18","doi-asserted-by":"crossref","first-page":"a025320","DOI":"10.1101\/cshperspect.a025320","article-title":"Topoisomerase inhibitors: fluoroquinolone mechanisms of action and resistance","volume":"6","author":"Hooper","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"key\n\t\t\t\t20180504013612_B19","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nature09197","article-title":"Type IIA topoisomerase inhibition by a new class of antibacterial agents","volume":"466","author":"Bax","year":"2010","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180504013612_B20","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1128\/AAC.00247-08","article-title":"Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors","volume":"52","author":"Miller","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"key\n\t\t\t\t20180504013612_B21","doi-asserted-by":"crossref","first-page":"E4492","DOI":"10.1073\/pnas.1700721114","article-title":"Thiophene antibacterials that allosterically stabilize DNA-cleavage complexes with DNA gyrase","volume":"114","author":"Chan","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"key\n\t\t\t\t20180504013612_B22","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1016\/j.bmcl.2008.07.117","article-title":"Synthesis and antibacterial activity of the C-7 side chain of 3-aminoquinazolinediones","volume":"18","author":"Hutchings","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"key\n\t\t\t\t20180504013612_B23","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1093\/nar\/gkt124","article-title":"Topoisomerase IV-quinolone interactions are mediated through a water-metal ion bridge: mechanistic basis of quinolone resistance","volume":"41","author":"Aldred","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20180504013612_B24","doi-asserted-by":"crossref","first-page":"19648","DOI":"10.1016\/S0021-9258(19)47162-7","article-title":"Tryptic fragments of the Escherichia coli DNA gyrase A protein","volume":"264","author":"Reece","year":"1989","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20180504013612_B25","first-page":"135","article-title":"Overexpression and purification of bacterial DNA gyrase","volume":"94","author":"Maxwell","year":"1999","journal-title":"Methods Mol. Biol."},{"key":"key\n\t\t\t\t20180504013612_B26","article-title":"SciPy: open source scientific tools for Python","author":"Jones","year":"2001"},{"key":"key\n\t\t\t\t20180504013612_B27","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1128\/AAC.45.7.1994-2000.2001","article-title":"Interaction between DNA gyrase and quinolones: effects of alanine mutations at GyrA subunit residues Ser(83) and Asp(87)","volume":"45","author":"Barnard","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"key\n\t\t\t\t20180504013612_B28","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1107\/S2053230X15015290","article-title":"Crystallization and initial crystallographic analysis of covalent DNA-cleavage complexes of Staphyloccocus aureus DNA gyrase with QPT-1, moxifloxacin and etoposide","volume":"71","author":"Srikannathasan","year":"2015","journal-title":"Acta Crystallogr. F Struct. Biol. Commun."},{"key":"key\n\t\t\t\t20180504013612_B29","doi-asserted-by":"crossref","first-page":"10048","DOI":"10.1038\/ncomms10048","article-title":"Structural basis of DNA gyrase inhibition by antibacterial QPT-1, anticancer drug etoposide and moxifloxacin","volume":"6","author":"Chan","year":"2015","journal-title":"Nat. Commun."},{"key":"key\n\t\t\t\t20180504013612_B30","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.1016\/j.bmcl.2013.07.013","article-title":"Novel hydroxyl tricyclics (e.g., GSK966587) as potent inhibitors of bacterial type IIA topoisomerases","volume":"23","author":"Miles","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"key\n\t\t\t\t20180504013612_B31","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"key\n\t\t\t\t20180504013612_B32","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1107\/S0907444911001314","article-title":"REFMAC5 for the refinement of macromolecular crystal structures","volume":"67","author":"Murshudov","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"key\n\t\t\t\t20180504013612_B33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"key\n\t\t\t\t20180504013612_B34","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1107\/S2059798317000067","article-title":"AceDRG: a stereochemical description generator for ligands","volume":"73","author":"Long","year":"2017","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"key\n\t\t\t\t20180504013612_B35","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1128\/AAC.34.6.1271","article-title":"Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli","volume":"34","author":"Yoshida","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"key\n\t\t\t\t20180504013612_B36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00338386","article-title":"Quinolone-resistant mutations of the gyrA gene of Escherichia coli","volume":"211","author":"Yoshida","year":"1988","journal-title":"Mol. Gen. Genet."},{"key":"key\n\t\t\t\t20180504013612_B37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1054\/drup.1998.0068","article-title":"Mechanisms of fluoroquinolone resistance","volume":"2","author":"Hooper","year":"1999","journal-title":"Drug Resist. updat."},{"key":"key\n\t\t\t\t20180504013612_B38","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1128\/AAC.01349-08","article-title":"Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance","volume":"53","author":"Beeton","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"key\n\t\t\t\t20180504013612_B39","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1073\/pnas.1525055113","article-title":"Fluoroquinolone interactions with Mycobacterium tuberculosis gyrase: Enhancing drug activity against wild-type and resistant gyrase","volume":"113","author":"Aldred","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"key\n\t\t\t\t20180504013612_B40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0301-4622(99)00047-2","article-title":"Energetics of Ca(2+)-EDTA interactions: calorimetric study","volume":"79","author":"Griko","year":"1999","journal-title":"Biophys. Chem."},{"key":"key\n\t\t\t\t20180504013612_B41","doi-asserted-by":"crossref","first-page":"22615","DOI":"10.1074\/jbc.273.35.22615","article-title":"The DNA gyrase-quinolone complex. ATP hydrolysis and the mechanism of DNA cleavage","volume":"273","author":"Kampranis","year":"1998","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20180504013612_B42","doi-asserted-by":"crossref","first-page":"e11338","DOI":"10.1371\/journal.pone.0011338","article-title":"Structural basis of gate-DNA breakage and resealing by type II topoisomerases","volume":"5","author":"Laponogov","year":"2010","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180504013612_B43","doi-asserted-by":"crossref","first-page":"12300","DOI":"10.1074\/jbc.M113.529164","article-title":"Fluoroquinolone-gyrase-DNA complexes: two modes of drug binding","volume":"289","author":"Mustaev","year":"2014","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20180504013612_B44","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1128\/AAC.00330-08","article-title":"Use of gyrase resistance mutants to guide selection of 8-methoxy-quinazoline-2,4-diones","volume":"52","author":"German","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"key\n\t\t\t\t20180504013612_B45","doi-asserted-by":"crossref","first-page":"10630","DOI":"10.1093\/nar\/gkt828","article-title":"On the structural basis and design guidelines for type II topoisomerase-targeting anticancer drugs","volume":"41","author":"Wu","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20180504013612_B46","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1126\/science.1204117","article-title":"Structural basis of type II topoisomerase inhibition by the anticancer drug etoposide","volume":"333","author":"Wu","year":"2011","journal-title":"Science"},{"key":"key\n\t\t\t\t20180504013612_B47","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1128\/AAC.04077-14","article-title":"Target-based resistance in Pseudomonas aeruginosa and Escherichia coli to NBTI 5463, a novel bacterial type II topoisomerase inhibitor","volume":"59","author":"Nayar","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"key\n\t\t\t\t20180504013612_B48","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1128\/AAC.03734-14","article-title":"Bacillus anthracis GrlAV96A topoisomerase IV, a quinolone resistance mutation that does not affect the water-metal ion bridge","volume":"58","author":"Aldred","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"key\n\t\t\t\t20180504013612_B49","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1038\/emboj.2009.223","article-title":"A non-canonical function of topoisomerase II in disentangling dysfunctional telomeres","volume":"28","author":"Germe","year":"2009","journal-title":"EMBO J."},{"key":"key\n\t\t\t\t20180504013612_B50","doi-asserted-by":"crossref","first-page":"8400","DOI":"10.1038\/srep08400","article-title":"Fitness profiling links topoisomerase II regulation of centromeric integrity to doxorubicin resistance in fission yeast","volume":"5","author":"Nguyen","year":"2015","journal-title":"Sci. Rep."},{"key":"key\n\t\t\t\t20180504013612_B51","doi-asserted-by":"crossref","first-page":"7387","DOI":"10.1021\/bi9603175","article-title":"DNA cleavage is not required for the binding of quinolone drugs to the DNA gyrase-DNA complex","volume":"35","author":"Critchlow","year":"1996","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20180504013612_B52","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1021\/cb500629k","article-title":"Bypassing fluoroquinolone resistance with quinazolinediones: studies of drug-gyrase-DNA complexes having implications for drug design","volume":"9","author":"Drlica","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"key\n\t\t\t\t20180504013612_B53","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1128\/AAC.00113-09","article-title":"Probing the differential interactions of quinazolinedione PD 0305970 and quinolones with gyrase and topoisomerase IV","volume":"53","author":"Pan","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"key\n\t\t\t\t20180504013612_B54","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nsmb.2388","article-title":"Structure of a topoisomerase II-DNA-nucleotide complex reveals a new control mechanism for ATPase activity","volume":"19","author":"Schmidt","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"key\n\t\t\t\t20180504013612_B55","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1093\/nar\/gkr018","article-title":"Use of divalent metal ions in the DNA cleavage reaction of topoisomerase IV","volume":"39","author":"Pitts","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20180504013612_B56","doi-asserted-by":"crossref","first-page":"8940","DOI":"10.1021\/bi900875c","article-title":"Metal ion interactions in the DNA cleavage\/ligation active site of human topoisomerase IIalpha","volume":"48","author":"Deweese","year":"2009","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20180504013612_B57","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1093\/nar\/gkn466","article-title":"Human topoisomerase IIalpha uses a two-metal-ion mechanism for DNA cleavage","volume":"36","author":"Deweese","year":"2008","journal-title":"Nucleic Acids Res."}],"container-title":["Nucleic Acids Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/nar\/article-pdf\/46\/8\/4114\/24783223\/gky181.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T04:48:56Z","timestamp":1660538936000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nar\/article\/46\/8\/4114\/4925761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,10]]},"references-count":57,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,3,10]]},"published-print":{"date-parts":[[2018,5,4]]}},"URL":"https:\/\/doi.org\/10.1093\/nar\/gky181","relation":{},"ISSN":["0305-1048","1362-4962"],"issn-type":[{"value":"0305-1048","type":"print"},{"value":"1362-4962","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,5,4]]},"published":{"date-parts":[[2018,3,10]]}}}